BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 29079914)

  • 1. MRI features of primary rare malignancies of the liver: A report from four university centres.
    Semelka RC; Nimojan N; Chandana S; Ramalho M; Palmer SL; DeMulder D; Parada Villavicencio C; Woosley J; Garon BL; Jha RC; Miller FH; Altun E
    Eur Radiol; 2018 Apr; 28(4):1529-1539. PubMed ID: 29079914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uncommon liver tumors: Case report and literature review.
    Wu CH; Chiu NC; Yeh YC; Kuo Y; Yu SS; Weng CY; Liu CA; Chou YH; Chiou YY
    Medicine (Baltimore); 2016 Sep; 95(39):e4952. PubMed ID: 27684838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contrast-enhanced multiple-phase imaging features in hepatic epithelioid hemangioendothelioma.
    Chen Y; Yu RS; Qiu LL; Jiang DY; Tan YB; Fu YB
    World J Gastroenterol; 2011 Aug; 17(30):3544-53. PubMed ID: 21941423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imaging features of hepatic sarcomatous carcinoma on computed tomography and gadoxetic acid-enhanced magnetic resonance imaging.
    Gu KW; Kim YK; Min JH; Ha SY; Jeong WK
    Abdom Radiol (NY); 2017 May; 42(5):1424-1433. PubMed ID: 28078380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocellular carcinoma and other hepatic malignancies: MR imaging.
    Roth CG; Mitchell DG
    Radiol Clin North Am; 2014 Jul; 52(4):683-707. PubMed ID: 24889167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiation of intrahepatic mass-forming cholangiocarcinoma from hepatocellular carcinoma on gadoxetic acid-enhanced liver MR imaging.
    Kim R; Lee JM; Shin CI; Lee ES; Yoon JH; Joo I; Kim SH; Hwang I; Han JK; Choi BI
    Eur Radiol; 2016 Jun; 26(6):1808-17. PubMed ID: 26373763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary malignant tumours in the non-cirrhotic liver.
    Lee DH; Lee JM
    Eur J Radiol; 2017 Oct; 95():349-361. PubMed ID: 28987692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesenchymal tumors of the liver.
    Mani H; Van Thiel DH
    Clin Liver Dis; 2001 Feb; 5(1):219-57, viii. PubMed ID: 11218917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiating primary hepatic angiosarcomas from hemangiomatosis and epithelioid hemangioendotheliomas using gadoxetic acid-enhanced and diffusion-weighted MR imaging.
    Seo JW; Kim SH; Kim AY; Jeong WK; Woo JY; Park WJ
    Jpn J Radiol; 2017 Nov; 35(11):655-663. PubMed ID: 28879422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CT and MRI diagnosis of hepatic epithelioid hemangioendothelioma.
    Lin J; Ji Y
    Hepatobiliary Pancreat Dis Int; 2010 Apr; 9(2):154-8. PubMed ID: 20382586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MRI features of combined hepatocellular- cholangiocarcinoma versus mass forming intrahepatic cholangiocarcinoma.
    Sammon J; Fischer S; Menezes R; Hosseini-Nik H; Lewis S; Taouli B; Jhaveri K
    Cancer Imaging; 2018 Feb; 18(1):8. PubMed ID: 29486800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imaging features of hepatocellular carcinoma compared to intrahepatic cholangiocarcinoma and combined tumor on MRI using liver imaging and data system (LI-RADS) version 2014.
    Horvat N; Nikolovski I; Long N; Gerst S; Zheng J; Pak LM; Simpson A; Zheng J; Capanu M; Jarnagin WR; Mannelli L; Do RKG
    Abdom Radiol (NY); 2018 Jan; 43(1):169-178. PubMed ID: 28765978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. State-of-the-art MR Imaging of Uncommon Hepatocellular Tumours: Fibrolamellar Hepatocellular Carcinoma and Combined Hepatocellularcholangiocarcinoma.
    Anysz-Grodzicka A; Podgorska J; Cieszanowski A
    Curr Med Imaging Rev; 2019; 15(3):269-280. PubMed ID: 31989878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pathology of liver tumors].
    Wittekind C
    Zentralbl Chir; 2000; 125(7):587-91. PubMed ID: 10960966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules.
    Terzi E; Iavarone M; Pompili M; Veronese L; Cabibbo G; Fraquelli M; Riccardi L; De Bonis L; Sangiovanni A; Leoni S; Zocco MA; Rossi S; Alessi N; Wilson SR; Piscaglia F;
    J Hepatol; 2018 Mar; 68(3):485-492. PubMed ID: 29133247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic epithelioid haemangioendothelioma (HEHE): a diagnostic dilemma between haemangioma and angiosarcoma.
    van Rosmalen BV; Verheij J; Phoa SSKS; van Gulik TM
    BMJ Case Rep; 2017 Nov; 2017():. PubMed ID: 29102969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging Features of Biphenotypic Primary Liver Carcinoma (Hepatocholangiocarcinoma) and the Potential to Mimic Hepatocellular Carcinoma: LI-RADS Analysis of CT and MRI Features in 61 Cases.
    Potretzke TA; Tan BR; Doyle MB; Brunt EM; Heiken JP; Fowler KJ
    AJR Am J Roentgenol; 2016 Jul; 207(1):25-31. PubMed ID: 26866746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignant liver tumors.
    Levy AD
    Clin Liver Dis; 2002 Feb; 6(1):147-64. PubMed ID: 11933586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imaging and clinical features of primary hepatic sarcomatous carcinoma.
    Shi D; Ma L; Zhao D; Chang J; Shao C; Qi S; Chen F; Li Y; Wang X; Zhang Y; Zhao J; Li H
    Cancer Imaging; 2018 Oct; 18(1):36. PubMed ID: 30314525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imaging findings of primary hepatic angiosarcoma on gadoxetate disodium-enhanced liver MRI: comparison with hepatic haemangiomas of similar size.
    Kim B; Byun JH; Lee JH; Park BJ; Kwon HJ; Lee JH; Lee SJ; Won HJ; Shin YM; Kim PN
    Clin Radiol; 2018 Mar; 73(3):244-253. PubMed ID: 29111237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.